Immunogenicity, Safety and Efficacy Comparison of Wockhardt’s Biosimilar Insulin Glargine—Glaritus® With Reference Product— Lantus®: Study Protocol &Amp; Early Data Trends
Open Journal of Endocrine and Metabolic Diseases
doi 10.4236/ojemd.2018.88016
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
Scientific Research Publishing, Inc,